Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...
Health experts say lenacapavir could reduce the number of global HIV infections significantly. But it needs to be cheaper to ...
FOX 5 spoke exclusively with a participant in a study for a new injectable drug to prevent HIV. Emory University medical ...
Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons,” published in the November 2024 issue of Infectious ...
In a population of cisgender men, transgender women, transgender men, and gender-nonbinary persons, the incidence of HIV is ...
"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...
Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates, mostly in ...
While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...
A deal that allows manufacturers to produce generic versions of lenacapavir has left out some Eastern European countries ...